期刊文献+

欣普贝生与催产素对40例足月引产疗效分析 被引量:1

下载PDF
导出
摘要 目的:探讨欣普贝生和催产素在足月引产中的应用效果。方法:收治足月引产产妇80例,随机分成对照组和观察组各40例。观察组给予普贝生10mg塞阴道引产;对照组给予催产素2.5U加入5%葡萄糖溶液500ml中静滴引产,观察比较两组宫颈评分的变化、引产成功率、临产时间、剖宫产率和对新生儿的影响。结果:观察组产妇用药后宫颈评分明显高于对照组,24小时引产成功率90%。对照组24小时引产成功率60.0%,两组比较差异有统计学意义(P<0.05)。欣普贝生的不良反应为子宫过度刺激,发生率为5%,但发生率低,将药取出后好转。结论:欣普贝生是一种安全、有效的促宫颈成熟药物。 Objective:To explore the effect of suppositories and oxytocin application in induced term labor.Methods:We selected 80 cases of maternal induced term labor in 2012 September to 2013 October.These pa-tients were randomly divided into the obser-vation group and the control group with 40 cases in each.Methods:The observation group was given 10mg propess into the vagi-na to induce labor.Continuous intravenous drip of 2.5U oxytocin with 5% glucose solu-tion 500ml of the control group to induce la-bor.We observed index of the two groups, such as cervical score,the successful rate of induced labor,labor time,the rate of cesarean section and the effect of cesarean section to neonatal.Results:The observation group of cervical score was significantly higher than control group.The successful rate of induced labor in 24 hours of observation group is 90% and control group is 60.0%.The differ-ence between the two groups was signifi-cant(P〈 0.05).The adverse reaction of propess was uterine hyperstimulation and the incidence rate was 5% .If we take the medicine out,the adverse reaction will be better.Conclusion:Propess is a safe,effective agent in promoting cervical ripening.
作者 孟磊
出处 《中国社区医师(医学专业)》 2013年第24期50-51,共2页
关键词 足月引产 欣普贝生 缩宫素 应用效果 Induced term labor Propess Oxytocin The application effect
  • 相关文献

参考文献6

二级参考文献19

  • 1曲晓红,李智,陈咏玫,李小敏,郭亚红,任丽娟.地诺前列酮栓剂用于127例足月妊娠引产效果的初步观察[J].中国临床医学,2004,11(5):906-907. 被引量:24
  • 2Witter FR.Prostug landin E2 preparation for preinduction cervical ripening clinical[J].Obster Gynecol,2000,43(3):469-471.
  • 3Ayaz A, Saeed S, Farooq M U, et al. Pre-labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management [J]. Taiwan J Obstet Gynecol, 2008,47(2) : 192-196.
  • 4Ara J, Noorami M. Induction of labour with oral misoprostol for prelabour rupture of mimbranes at term [J]. J Pak Med Assoc, 2005,55(5) : 180-183.
  • 5Da-Graca-Krupa F, Cecatti J G, de-Castro-Surita F G, et al. Misoprostol versus expectant management in premature rupture of mimbranes at term [J]. BJOG, 2005,112(9) : 1284-1290.
  • 6Frohn W E, Simmons S, Carlan, S J. Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks [J]. Obstet Gynecol, 2002,99(2) : 206-210.
  • 7Ozden S, Delikara M N, Arci A, et al. Intravaginal misoprostol vs. expectant management in premature rupture of membranes with low Bishop scores at term [J]. Int J Gynaecol Obstet, 2002,77(2) : 109-115.
  • 8Zamzami T Y. Prelabor rupture of membranes at term in low-risk women: induce or wait [J]? Arch Gynecol Obstet, 2006, 273 (5) : 278-282.
  • 9曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2163-2169.
  • 10Mazouni C, Provensal M, Menard JP, et al. Evaluation of controlled-release dinoprostone propess for labor induction [ J ]. Gynecol Obstet Fertil,2006 ,34 :489-492

共引文献98

同被引文献12

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部